Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

The realization of CRISPR gene therapy

The inaugural CRISPR-based drug Casgevy has been approved by several medical agencies, with other CRISPR-based therapies currently in clinical trials. Although there are technological hurdles to overcome, chemical biology has a vital role in developing recent breakthroughs in base editing, prime editing and epigenetic editing into future treatments.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: A non-exhaustive summary of ongoing clinical trials or preclinical therapies and their targeted organs, genes and systems.

References

  1. Baker, D. J., Arany, Z., Baur, J. A., Epstein, J. A. & June, C. H. Nature 619, 707–715 (2023).

    Article  CAS  PubMed  Google Scholar 

  2. Friskes, A. et al. Nucleic Acids Res. 50, 9930–9947 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kabadi, A. M. et al. Curr. Opin. Biomed. Eng. 29, 100517 (2024).

    Article  CAS  Google Scholar 

  4. Jeong, M., Lee, Y., Park, J., Jung, H. & Lee, H. Adv. Drug Deliv. Rev. 200, 114990 (2023).

    Article  CAS  PubMed  Google Scholar 

  5. Banskota, S. et al. Cell 185, 250–265.e16 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hamilton, J. R. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-02085-z (2024).

    Article  PubMed  Google Scholar 

  7. Raguram, A., Banskota, S. & Liu, D. R. Cell 185, 2806–2827 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Modell, A. E., Siriwardena, S. U., Shoba, V. M., Li, X. & Choudhary, A. Curr. Opin. Chem. Biol. 60, 113–121 (2021).

    Article  CAS  PubMed  Google Scholar 

  9. Nihongaki, Y., Otabe, T., Ueda, Y. & Sato, M. Nat. Chem. Biol. 15, 882–888 (2019).

    Article  CAS  PubMed  Google Scholar 

  10. Gibbs, W. W. Nature 508, 168–170 (2014).

    Article  CAS  PubMed  Google Scholar 

  11. Cappelluti, M. A. et al. Nature 627, 416–423 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Y.M. is supported by a Cancer Research Institute Dr. Keith Landesman Memorial Fellowship (CRI5247). L.S.Q. acknowledges support by National Science Foundation, National Institutes of Health and the Chau Hoi Shuen Foundation Limited. This work is supported by National Human Genome Research Institute (R21HG013133) and NIH Director’s Pioneer Award (DP1NS137219). L.S.Q. is a Chan Zuckerberg Biohub – San Francisco Investigator.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lei S. Qi.

Ethics declarations

Competing interests

L.S.Q. is a founder of Epic Bio and scientific advisor of Laboratory of Genomic Research and Kytopen Corp. Y.M. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, Y., Qi, L.S. The realization of CRISPR gene therapy. Nat Chem Biol 20, 791–795 (2024). https://doi.org/10.1038/s41589-024-01645-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-024-01645-x

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing